CYCC (Cyclacel Pharmaceuticals) Net earnings per share growth this year

CYCC (Cyclacel, Inc.) - company brandmark

A lack of market influence due to early-stage testing makes Cyclacel Pharmaceuticals (CYCC) dependent on external financing. The year-over-year change in earnings per share helps identify trend reversals, and the latest figure currently stands at 0.00. The development of therapy relies on synergy with research centers, while bioanalysis automation allows for the scaling of new molecule screening without increasing headcount.

Earnings per share growth in current year: Cyclacel Pharmaceuticals, Inc. (CYCC) for 07/04/2022 - 09/12/2025

Financial and market metric breakdowns for cyclacel.com (CYCC)

Summary company analysis:CYCC Cyclacel Pharmaceuticals
Signature product of Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals (CYCC) focuses on developing CDK inhibitors amidst stringent FDA regulations and high R&D costs. The eps_yy_co metric digitizes the efficiency of these investments by measuring the percentage deviation of current earnings per share from the same period last year. Analyzing the year-over-year EPS growth trend allows for the identification of slowing growth rates prior to official reports, preventing the purchase of an overvalued asset.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year herontx.com|NVCT: Earnings growth in current year|Net earnings per share change in current year Coherus CHRS|Net earnings per share growth this year CRBP|Earnings per share growth rate in current year Cardiff Oncology CRDF|Net earnings per share growth this year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Earnings per share increase in current year|Lixte Biotechnology - Net earnings per share growth this year|Net earnings per one share growth for the current year CTXR (Citius Pharma)|Cellectar - Earnings growth in current year|Earnings per share increase in current year BLRX (BioLineRx Corp)|CANF: Earnings growth in current year|Earnings per share growth rate in current year Aprea (APRE)|Earnings per share growth in current year kaziatherapeutics.com|SLXN: Earnings per share increase in current year|Earnings growth in current year NCNA|Earnings growth in current year Chimerix Inc (CMRX)|Earnings per share growth in current year G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year